Compare GH & WPC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | GH | WPC |
|---|---|---|
| Founded | 2011 | 1973 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical Specialities | Real Estate Investment Trusts |
| Sector | Health Care | Real Estate |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 13.3B | 15.3B |
| IPO Year | 2018 | 1998 |
| Metric | GH | WPC |
|---|---|---|
| Price | $86.76 | $72.88 |
| Analyst Decision | Strong Buy | Hold |
| Analyst Count | 19 | 9 |
| Target Price | ★ $119.79 | $73.11 |
| AVG Volume (30 Days) | ★ 2.0M | 1.1M |
| Earning Date | 05-07-2026 | 04-28-2026 |
| Dividend Yield | N/A | ★ 5.11% |
| EPS Growth | ★ 6.74 | N/A |
| EPS | N/A | ★ 1.33 |
| Revenue | $982,021,000.00 | ★ $1,716,485,000.00 |
| Revenue This Year | $33.30 | $6.59 |
| Revenue Next Year | $28.27 | $6.16 |
| P/E Ratio | ★ N/A | $54.24 |
| Revenue Growth | ★ 32.88 | 8.43 |
| 52 Week Low | $36.36 | $59.77 |
| 52 Week High | $120.74 | $75.69 |
| Indicator | GH | WPC |
|---|---|---|
| Relative Strength Index (RSI) | 46.59 | 57.42 |
| Support Level | $82.33 | $66.81 |
| Resistance Level | $98.58 | $74.20 |
| Average True Range (ATR) | 4.64 | 1.23 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 44.51 | 67.17 |
Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.
W.P. Carey Inc is a real estate investment trust principally involved in the ownership of properties located in the U.S., Western Europe, and Northern Europe. W.P. Carey organizes its operations into Real Estate and Investment Management segments. The vast majority of the company's income is derived from its Real Estate division in the form of lease revenue from long-term agreements with companies. W.P. Carey's real estate portfolio is comprised of single-tenant office, industrial, warehouse, and retail facilities located around the world. majority of the company's revenue comes from properties in the USA. Its Investment Management unit generates revenue from providing real estate advisory and portfolio management services to other REITs.